AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇳🇬
Sacubitril; Valsartan in Nigeria
9 products registered with NAFDAC — 9 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Sacuvan 24 mg/26 mg Tablets Tablet | A4-100798 | Hetero Labs Nigeria Limited | active | 26 Mar 2029 |
| Sacuvan 97/103 Tablets Tablet | A4-100799 | Hetero Labs Nigeria Limited | active | 26 Mar 2029 |
| Sacuvan 49/51 Tablets Tablet | A4-100800 | Hetero Labs Nigeria Limited | active | 26 Mar 2029 |
| Uperio 50mg Tablet** Tablet | B4-7690 | Novartis Nigeria Limited | active | 26 Jul 2028 |
| Uperio 200 mg Tablet Tablet | B4-7238 | — | active | 26 Jul 2028 |
| Uperio 100mg Tablet** Tablet | B4-7237 | Novartis Nigeria Limited | active | 5 Jul 2028 |
| Vacutro Tablets Tablet | C4-2048 | Getz Pharma Nigeria Limited | active | 14 Dec 2027 |
| Vacutro Tablet | C4-2049 | Getz Pharma Nigeria Limited | active | 14 Dec 2027 |
| Vacutro (check NRN) Tablet | 2 X 7 | Getz Pharma Nigeria Limited | active | 14 Dec 2027 |
Sacubitril; Valsartan — NAFDAC Registration Details
NAFDAC (Nigeria) has 9 registered products containing Sacubitril; Valsartan, of which 9 are currently active. Data is sourced directly from the official NAFDAC drug register and refreshed daily.
Track Sacubitril; Valsartan registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.